Blood Glucose Device Market

Blood Glucose Device (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.

Blood Glucose Device Market contains market size and forecasts of Blood Glucose Device (SMBG) in global, including the following market information:

• Global Blood Glucose Device (SMBG) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Blood Glucose Device (SMBG) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Blood Glucose Device (SMBG) companies in 2021 (%)

The global Blood Glucose Device (SMBG) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Strips Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Blood Glucose Device (SMBG) include Roche, Lifescan, Abbott, Terumo and Ascensia (Bayer), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Blood Glucose Device (SMBG) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blood Glucose Device (SMBG) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Blood Glucose Device (SMBG) Market Segment Percentages, by Type, 2021 (%)

• Strips
• Glucose Meter
• Lancet

Global Blood Glucose Device (SMBG) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Blood Glucose Device (SMBG) Market Segment Percentages, by Application, 2021 (%)

• Public Hospital
• Private Hospital
• Clinics
• Pharmacy Shops

Global Blood Glucose Device (SMBG) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Blood Glucose Device (SMBG) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Blood Glucose Device (SMBG) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Blood Glucose Device (SMBG) revenues share in global market, 2021 (%)
• Key companies Blood Glucose Device (SMBG) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Blood Glucose Device (SMBG) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Lifescan
• Abbott
• Terumo
• Ascensia (Bayer)